C47H60N7O10P Guanosine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-(2- methoxyethyl)-N-(2-methyl-1-ocsopropyl)-, 3′ – [2-cyanoethyl N ,N-bis (1-methylethyl)phosphoramidite] (ACI)

GWênau Canonaidd

N#CCCOP(OC1C(OC(N2C=NC=3C(=O)N=C(NC(=O)C(C)C)NC32)C1OCCOC)COC(C=4C=CC=CC4)(C5=CC =C(OC)C=C5)C6=CC=C(OC)C=C6) N(C(C)C)C(C)C

GWênau Isomerig

C(OC[C@@H]1[C@H](OP(N(C)C)C(C)C)OCCC#N)[C@@H](OCCOC)[C@@ H](O1)N2C3=C(N=C2)C(=O)N=C(NC(C(C)C)=O)N3)(C4=CC=C (OC)C=C4)(C5=CC=C(OC)C=C5)C6=CC=CC=C6

InChI

InChI= 1S/C47H60N7O10P/c1-30(2)43(55)51-46-50-42-39(44(56)52-46)49-29-53(42)45-41(60-27-26- 57-7)40(64-65(62-25-13-24-48)54( 31(3)4)32(5)6)38(63-45)28-61-47(33-14-11-10-12-15-33,34-16-20-3 6(58-8)21-17-34)35-18-22-37(59-9)23-19-35/h10-12,14-23,29-32,38 ,40-41,45H,13,25-28H2,1-9H3,(H2,50,51,52,55,56)/t38-,40-,41-,45-,65?/m1/s1

Allwedd InChI

LADCDGNEBIQAAU-SBCRAQIVSA-N

17 Enwau Eraill ar y Sylwedd hwn

Guanosin, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′ - [2-cyanoethyl bis(1- methylethyl)phosphoramidite] (9CI); 17: PN: US20030212017 TUDALEN: 20 dilyniant hawlio; 18: PN: US20030211606 TUDALEN: 20

dilyniant honedig; 19: PN: US20040005569 TUDALEN: 22 hawlio dilyniant; 21: PN: US20040006030 TUDALEN: 23 hawlio dilyniant; 21: PN: US20040014047 TUDALEN: 21 hawlio dilyniant; 21: PN: US20040014049 TUDALEN: 21 hawlio dilyniant; 22: PN: US20030198965 PAG

E: 20 dilyniant hawlio; 22: PN: US20040005570 TUDALEN: 21 hawlio dilyniant; 22: PN: US20040014048 TUDALEN: 21 hawlio dilyniant;

22: PN: US20040014050 TUDALEN: 21 hawlio dilyniant; 23: PN: US20040005565 TUDALEN: 17- 22 hawlio dilyniant; 23: PN: US20040

014051 TUDALEN: 23 dilyniant honedig; 24: PN: US20040014699 TUDALEN: 21 hawlio dilyniant; 25: PN: US20040006029 TUDALEN: 23 hawlio dilyniant; 25: PN: WO03106645 TUDALEN: 73 hawlio dilyniant; 96: PN: US20040005707 TUDALEN: 21 hawlio dilyniant